Taj Worldwide | Taj Group | Media | Career | FAQs | Feedback | contact us
 
Taj Logo
especially Products
 
Quality Medicines Api Generic Manufacturing For Doctors Brands Newsroom
 

Famexavir ® Taj Products

 
HOME >> PRODUCTS >> Taj Products >> Famexavir
Taj  ALL Products View Products According to Category


 

Each tablet contains

Composition

Famciclovir ........................................................................250 mg
Famciclovir ........................................................................500 mg

Indications: Herpes Zoster: Famexavir (famciclovir) is indicated for the treatment of acute herpes zoster (shingles), treatment or suppression of recurrent genital herpes in immunocompetent patients, and treatment of recurrent mucocutaneous herpes simplex infections in HIV-infected patients.

Description
Famciclovir undergoes rapid biotransformation to the active compound, penciclovir, which is phosphorylated by viral thymidine kinase in HSV-1, HSV-2, and VZV-infected cells to a monophosphate form; this is then converted to penciclovir triphosphate and competes with deoxyguanosine triphosphate to inhibit HSV-2 polymerase (eg, herpes viral DNA synthesis/replication is selectively inhibited)

Warnings/Precautions
Has not been established for use in initial episodes of genital herpes, patients with ophthalmic or disseminated zoster, or in immunocompromised patients with herpes zoster. Dosage adjustment is required in patients with renal insufficiency. Tablets contain lactose; do not use with galactose intolerance, severe lactase deficiency, or glucose-galactose malabsorption syndromes. Safety and efficacy have not been established in children <18 years of age.

Contraindications
Hypersensitivity to famciclovir, penciclovir, or any component of the formulation

Dosage and Administration
Adults : Herpes zoster: 250 mg three times daily for 7 days or 750 mg once daily for 7 days (500 mg three times daily for 10 days in immunocompromised). Genital herpes: First episode: 250 mg three times daily for 5 days; recurrent infection, 125 mg twice daily for 5 days (500 mg twice daily for 7 days in all episodes in immunocompromised). Suppression of recurrent genital herpes: 250 mg twice daily (500 mg twice daily in HIV patients) interrupted every 6-12 months. Children: Not recommended

Interactions
Uricosurics: probenicid possibly reduces famciclovir excretion thereby increasing plasma concentration

Dosage
As per the physician’s advice.

Presentations
10 tablets
7 tablets

 

Note : This product information is intended only for residents of the India. Taj Pharmaceuticals Limited,  medicines help to treat and prevent a range of conditions—from the most common to the most challenging—for people around the world.

Information for Health Care Professionals

*** Please consult local Prescribing Information for any product before use. This website is an international information resource for healthcare professionals with an interest in disease management. This website is not intended to replace the advice of a qualified healthcare professional. Above brand is a trademark of the Taj group of companies (Taj Pharmaceuticals Limited).

 



Stop Aids

 

 

 

 

 

 










 

 

 

 

 

 

              
 Print page   Send by mail

 



 

   
   
PRODUCTS
 
 
   
   
   
  india flag
  The Taj Pharmaceuticals Limited (Taj Group) has operations in every major international market
    AFRICA
  ASIA PACIFIC
  EUROPE
  MIDDLE EAST
  THAILAND
  BANGLADESH
  NORTH AMERICA
  SOUTH AMERICA
  RUSSIA
  NEWZELAND
  UNITED KINGDOM
 

   

 

 

 

 

 

 

 

 

 

 
 www.tajpharma.com

   

 

About Taj

Company

Products Diseases Health Divisions Media R & D Sustainability
Figure & Reports Investors

Countries

Brochure E-mail us Export & Import
Vacancies | C & F Agency | Distributor | Group Companies | History | Enquire Form | Countries | Pharma Technology
 Contact | Sitemap | User Terms and Conditions | Privacy and Cookie Statement